Top Tweets for #cemarkonly
Hear from Dr. Dierk Scheinert about the first ever prospective randomized 414 pt head-to-head trial studying the latest generation Ranger DCB against InPact DCB. “same results with ~half the drug” #EHJournal #LevelOneEvidence #PAD #CEMarkOnly
COMPARE RCT shows similar key outcomes between low-and high-dose drug-coated balloons (Dierk Scheinert) - https://t.co/s3QwBHOd9V @TimYatesMD @UniLeipzig @krosenfieldMD @hmpVDM @PK_MountSinai @nick_inston @Thuaimer @JimGMelton @SandipNandhra @Kniery_Bird #AlwaysBLearning
Congrats & TY to Dr. Steiner and all the investigators. COMPARE, the first head-to-head DCB trial re-affirms #RangerDCB high efficacy in complex lesions (12 cm, 41% CTO, 50% mod/sev calcium). #CEMarkOnly #PAD
Join us in the #LINC2020 video studio for a discussion of the COMPARE trial 12-month data, presented for the first time by Sabine Steiner, MD. https://t.co/OSEGMxr613
Congrats to Prof. Dierk Scheinert & Dr. Sabine Steiner for the first H2H 1:1 RCT trial & simultaneous publication in EHJ #EvidenceBasedMedicine #RangerDCB #CEMarkOnly @escardio
Late Breaking @ #LINC2020 COMPARE trial: Worlds 1st head to head DCB trial comparing low dose #RangerDCB vs high dose IN.PACT. 1 yr results show similar patency for Ranger w/ half the drug. K-M primary patency of 88.4% Ranger vs 89.4% IN.PACT. #CEMarkOnly
Ranger II results are in at #LINC2020: full 12mo cohort data shows an 89.8% K-M primary patency w/ Ranger vs 74% w/ PTA. Significantly lower TLR Rate for #RangerDCB at 5.5% vs 16.5% for PTA. #CEMarkOnly Excited to continue my career advancing #EvidenceBasedMedicine w/ @bsc_pi.
Late Breaking @ #LINC2020 COMPARE trial: Worlds 1st head to head DCB trial comparing low dose #RangerDCB vs high dose IN.PACT. 1 yr results show similar patency for Ranger w/ half the drug. K-M primary patency of 88.4% Ranger vs 89.4% IN.PACT. #CEMarkOnly
TY Dr. Andrej Schmidt for a great live case out of Leipzig at #ISET2020 today using 6x80 #EluviaDES proximal and #RangerDCB distal to treat a complex lesion #PAD [Ranger #CEMarkOnly]
Proud to support the first & only randomized, sham controlled trial in #PAE. Thinking of Dr. Pisco et al whose legacy will live on with this landmark publication. Committed to advancing science in #Irad. #MIIP #LevelOneEvidence #BPH #CEMarkOnly
https://t.co/LpUFPuK66A
#LateBreaker @ #VIVA19: #RangerDCB 12mo results show a Kaplan Meier primary patency of 89.2% compared to 72.9% in pts treated w/ standard PTA & Ranger DCB had a significantly lower TLR rate of 6%, in contrast to 17.9% PTA. #CEMarkOnly @VIVAPhysicians
#VIRTUS trial quality of life results presented @ #AVF19 by Dr. William Marston: At 12 months, ~65% of patients saw rVCSS improvement of 3 or more #VenousDisease #ViciStent #CEMarkOnly
@mms62786 75% pts were Chronic Post Thrombotic, 66% Severe VCSS >8, 25% CEAP Class C5 & C6, 31% Total Occlusions and 32% involving the entire iliofemoral segment. Happy to send the podium slides if u wish. More info here: https://t.co/rwDZuV5Vwt #DVT #VenousDisease #VICIStent #CEMarkonly
Busy morning at #LINC2019: Dr. Scheinert presents world’s 1st H2H #DCB trial COMPARE: 2 yr results show new gen Ranger DCB demonstrated similar patency & freedom from TLR w/ low dose compared to higher dose IN.PACT DCB #PAD #H2HTrial #Level1Evidence #CEMarkOnly
Happening Now @ #LINC2019: VIRTUS clinical trial results of VICI Stent primary endpoint achieved 84% primary patency at 12 months in severely diseased patients w/ challenging lesions #PTS #VICIStent #VenousDisease #CEMarkOnly
Today @ #LINC: Dr. Bill Gray & Prof. Dierk Scheinert sharing two H2H drug-eluting clinical trial designs (IMPERIAL & COMPARE-1) plus a difficult live case by Prof. Andrej Schmidt who took a retrograde approach w/ Eluvia in the mid SFA & Ranger in the P1 segment #PAD #CEMarkOnly
Exciting news in UK today: 1st worldwide Ranger DCB Long Length implant by Dr. James Kirk! 71 y/o F who had previous angioplasty #CEMarkOnly
Last Seen Hashtags on Sotwe
Trends for you
Most Popular Users
Elon Musk 
@elonmusk
240.8M followers
Barack Obama
@barackobama
119.2M followers
Donald J. Trump
@realdonaldtrump
111.7M followers
Cristiano Ronaldo
@cristiano
111.1M followers
Narendra Modi
@narendramodi
107M followers
Rihanna
@rihanna
97.8M followers
NASA
@nasa
92.2M followers
Justin Bieber
@justinbieber
91M followers
KATY PERRY
@katyperry
87.9M followers
Taylor Swift
@taylorswift13
81.7M followers
Lady Gaga
@ladygaga
73.3M followers
Virat Kohli
@imvkohli
70.3M followers
Kim Kardashian
@kimkardashian
69.9M followers
YouTube
@youtube
68.7M followers
Bill Gates
@billgates
64M followers
Neymar Jr
@neymarjr
63.1M followers
The Ellen Show
@theellenshow
62.4M followers
CNN
@cnn
61.9M followers
Selena Gomez
@selenagomez
61M followers
X
@x
60.8M followers